Friday, March 7, 2025

The Methamphetamine Epidemic: Evidence for Addressing the Issue

Steven Shoptaw, PhD

Meth-PAH: Pathophysiology and Genetic Contributions

Vinicio de Jesus Perez, MD

Managing Methamphetamine Substance Use Disorder

Michael Incze, MD

Collaborative Care Models

Katharine Clapham, MD

Panel Discussion / Audience Q&A

Moderator: Eleni Tseliou, MD
Discussants: Steven Shoptaw, PhD;
Vinicio de Jesus Perez, MD; Michael Incze, MD;
Katharine Clapham, MD

Diverse Populations and Access to Care

Lana Melendres-Groves, MD

Understanding Inequities in Access to Lung Transplantation for Patients with PAH

Nicholas Kolaitis, MD, MAS

Regional Variation in PAH in the US

Peter Leary, MD, PhD

Emerging Technologies in Telehealth

Raymond Benza, MD, FACC

Panel Discussion / Audience Q&A

Moderator: Mrinalini Krishnan, MD
Discussants: Lana Melendres-Groves, MD;
Nicholas Kolaitis, MD, MAS
Peter Leary, MD, PhD; Raymond Benza, MD, FACC

CTEPH Update

• Genetics of CTEPH

Mark Dodson, MD

• Management of CTEPH

Josanna Rodriguez-Lopez, MD

ILD-PH: Current Therapies and Pathways of Interest

Rajan Saggar, MD

Panel Discussion / Audience Q&A

Moderator: Richard Channick, MD
Discussants: Mark Dodson, MD;
Josanna Rodriguez-Lopez, MD; Rajan Saggar, MD

Recent Advances in Treatments for Pulmonary Hypertension

Ronald Zolty, MD, PhD

Antiproliferative Therapies

Paul Yu, MD, PhD

Panel Discussion / Audience Q&A

Moderator: Jean Elwing, MD, FCCP
Discussants: Ronald Zolty, MD, PhD;
Paul Yu, MD, PhD